Abstract
Diagnostic protocols for the assessment of small airway disease have been advanced to optimise the clinical management of patients with asthma https://bit.ly/3lpECHO
Extract
The paradigm of “small airway disease” (SAD) continues to be advanced with considerable enthusiasm by clinicians and scientists alike [1, 2], having full knowledge that the binary classification of airways as “small” or “large” is somewhat arbitrary [3, 4]. Nonetheless, important questions that remain unanswered are: 1) how does SAD manifest; 2) how do we detect SAD, ideally in a cost-effective manner that can be adopted in primary care; and finally 3) once a patient has been classified as having SAD, what can we do about it? The second of these questions is amply addressed in the present issue of the European Respiratory Journal by Kocks et al. [5].
Footnotes
Conflict of interest: None declared.
- Received December 1, 2022.
- Accepted February 6, 2023.
- Copyright ©The authors 2023. For reproduction rights and permissions contact permissions{at}ersnet.org